Abstract
IntroductionPneumocystis jirovecii pneumonia (PJP) is an opportunistic infection of immunocompromised hosts with significant morbidity and mortality. The current standard of care, trimethoprim-sulfamethoxazole (TMP-SMX) at a dose of 15–20 mg/kg/day, is...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have